Terumo Corporation
Terumo Corporation (TRUMF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
trumf · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Terumo CorporationYou TRUMF | $20.1B | 24.79x | -12.8% | $92.14 |
 Coloplast A/S CLPBF | $11.9B | 33.36x | +17.3% | $16.10 |
 Coloplast A/S CLPBY | $13.4B | 35.71x | +25.6% | $1.52 |
 Wellbeing Digital Sciences Inc. KONEF | $0M | N/A | — | -$0.21 |
 Olympus Corporation OCPNF | $12.3B | 24.00x | -15.6% | $61.70 |
 Orion Oyj ORINY | $22.9B | 36.71x | +29.1% | $0.85 |
 Otsuka Holdings Co., Ltd. OTSKF | $34.6B | 12.41x | -56.4% | $685.66 |
Industry Average 5 peers with valid PE | — | 28.44x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Terumo Corporation (TRUMF) measures how much investors pay for each dollar of the company's trailing earnings. TRUMF's current PE ratio of 24.79x is calculated by dividing its stock price of $13.60 by its TTM earnings per share of $92.14.
Frequently asked questions
TRUMF pe ratio · 6 questionsTRUMF's current PE ratio is 24.79x as of 2026-06-10, based on a stock price of $13.60 and TTM EPS of $92.14. Data sourced from Financial Modeling Prep via TRUMF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Terumo Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10